MIRA
INFORM REPORT
|
Report Date : |
30.11.2012 |
IDENTIFICATION DETAILS
|
Name : |
NENTAR & CO., INC. |
|
|
|
|
|
|
Registered Office : |
|
|
|
|
|
|
|
Country : |
|
|
|
|
|
|
|
Date of Incorporation : |
31.05.2010 |
|
|
|
|
|
|
Com. Reg. No.: |
421000000074403 |
|
|
|
|
|
|
Legal Form : |
Shares Limited Company |
|
|
|
|
|
|
Line of Business : |
Subject is engaged in selling researching, developing, manufacturing and
selling pharmaceutical intermediates and chemical pharmaceuticals. |
|
|
|
|
|
|
No. of Employees : |
158 |
|
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
|
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Since the late 1970s
|
Source : CIA |
COMPANY NAME
NENTAR & CO.,
INC.
NO. 197 ORIENTAL
ROAD, HIGH-TECH DEVELOPMENT ZONE, JINGZHOU
HUBEI PROVINCE 434000
PR CHINA
TEL: 86 (0)
716-8303013/8303176/8303168
FAX: 86 (0)
716-8303480
EXECUTIVE SUMMARY
DATE OF REGISTRATION : MAY 31, 2010
REGISTRATION NO. : 421000000074403
LEGAL FORM : Shares limited company
CHIEF EXECUTIVE :
CHEN LIEQUAN (LEGAL REPRESENTATIVE)
REGISTERED CAPITAL : CNY 75,000,000
staff :
158
BUSINESS CATEGORY : r & d & manufacturing & trading
Revenue :
n/a (AS
OF DEC. 31, 2011)
EQUITIES :
n/a (AS
OF DEC. 31, 2011)
WEBSITE : www.jznengte.com
E-MAIL :
sales@jznengte.com
PAYMENT :
AVERAGE
MARKET CONDITION : AVERAGE
FINANCIAL CONDITION : n/a
OPERATIONAL TREND : fairly steady
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE :
CNY 6.23 = USD 1
Adopted
abbreviations (as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
OPERATIONAL TREND & GENERAL
REPUTATION
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
LEGAL STATUS & HISTORY
***Note: SC’s
correct name should be the heading one, instead of the given name- Nenter & Co Inc.
SC was established as a Shares limited company of PRC with State
Administration of Industry & Commerce (SAIC) under registration No.:
421000000074403 on May 31, 2010.
SC’s Organization Code Certificate No.:
55394739-2
SC’s registered capital: CNY 75,000,000
SC’s paid-in capital: CNY 75,000,000
Registration Change Record:-
No significant changes of SC have been noted
in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief executives are
as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Wang Quansheng |
2.67 |
|
Yang Zhicheng |
20.31 |
|
Zhejiang Manbo Investment & Management Co., Ltd. |
5.00 |
|
Cai Heting |
15.40 |
|
Chen Liequan |
25.59 |
|
Zhang Wenqi |
16.92 |
|
Zhejiang Wanlun Investment Partnership Enterprise (Limited
Partnership) |
3.00 |
|
Hangzhou Lianchuang Yongyi Venture Capital Partnership Enterprise
(Limited Partnership) |
8.00 |
|
Qin Huiling |
3.11 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative, Chairman, and General Manager |
Chen Liequan |
RECENT DEVELOPMENT
SC has already passed ISO 9001:2008 quality system authentications.
SHAREHOLDER CHART &
BACKGROUND
Name %
of Shareholding
Wang Quansheng 2.67
Yang Zhicheng 20.31
Zhejiang Manbo Investment & Management Co., Ltd. 5.00
Cai Heting 15.40
Chen Liequan 25.59
Zhang Wenqi 16.92
Zhejiang Wanlun Investment Partnership Enterprise (Limited Partnership) 3.00
Hangzhou Lianchuang Yongyi Venture Capital Partnership Enterprise
(Limited Partnership) 8.00
Qin Huiling 3.11
Zhejiang Manbo Investment & Management Co., Ltd.
----------------------------------------------------------------------
Registration No.: 330000000045806
Date of Registration: December 29, 2009
Legal Form: Limited Liabilities Company
Registered Capital: CNY 300,000,000
Legal Representative: Guo Dongshao
Zhejiang Wanlun Investment Partnership Enterprise (Limited Partnership)
----------------------------------------------------------------------------------------------
Registration No.: 330100000117972
Date of Registration: April 16, 2010
Registered Capital: CNY 10,000,000
Legal Representative: Fang Shuqiang
Hangzhou Lianchuang Yongyi Venture Capital Partnership Enterprise
(Limited Partnership)
--------------------------------------------------------------------------------------------------------------------
Registration No.: 330100000132374
Registered Capital: CNY 700,000,000
MANAGEMENT
Chen Liequan,
Legal Representative, Chairman, and General Manager
-------------------------------------------------------------------------------------------------------
Gender: M
Working experience (s):
At present, working in SC as legal representative, chairman, and general
manager
BUSINESS OPERATION
SC’s registered business scope includes researching, developing,
manufacturing and selling new type of pharmaceutical intermediate not limited
by the state; related technology services and technology transfer; researching,
developing, manufacturing and selling other non-polluting chemical products;
and international trade.
SC is mainly engaged in selling researching, developing, manufacturing
and selling pharmaceutical intermediates and chemical pharmaceuticals.
SC’s products mainly include:
Montelukast Intermediates
Cresol Series
APIs
Chiral compounds and others
|
Products |
CAS No. |
|
2-(2-(3-(2-(7-chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol |
142569-70-8 |
|
methyl
[e]-2-[3-(s)-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate |
142569-69-5 |
|
methyl 2-(3-{(e)-3-[2-(7-chloro-2-quinolyl)vinyl]phenyl}-3-oxopropyl)benzoate |
14 |
|
4965-33-7 |
|
|
626-19-7 |
|
|
108-39-4 |
|
|
2416-94-6 |
|
|
95-87-4 |
|
|
105-67-9 |
|
|
576-26-1 |
|
|
697-82-5 |
|
|
527-35-5 |
|
|
134-63-4 |
|
|
15 |
|
|
196929-78-9 |
|
|
343338-28-3 |
|
|
18531-99-2 |
|
|
18531-94-7 |
|
|
3886-70-2 |
|
|
10420-89-0 |
SC sources its materials 100% from the domestic market. SC sells 60% of
its merchandises in domestic market, and 40% to overseas market, mainly Southeast Asia, etc.
The buying terms of SC include Check, T/T and Credit of 30-60 days. The
payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.
Staff &
Office:
--------------------------
SC is known to have approx. 158
staff at present.
SC owns an area as its operating office and factory, but the detailed
information is unknown.
RELATED COMPANY
SC is not known to have any subsidiary at present.
PAYMENT
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not provide any name of
trade/service suppliers and we have no other sources to conduct the enquiry at
present.
Delinquent payment record: None in our database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
BANKING
The bank information of SC is not filed in local SAIC.
FINANCIALS
SC’s financials are not filed in local SAIC, and SC also refused to
release the details.
CONCLUSIONS
SC is considered medium-sized in its line with 2 years business history.
Taking into consideration of SC’s general performance, reputation as well as
market conditions
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.20 |
|
|
1 |
Rs.88.37 |
|
Euro |
1 |
Rs.71.47 |
INFORMATION DETAILS
|
Report
Prepared by : |
NLM |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.